LSIPR 50 2016: David Rosenberg and Jörg Thomaier

Name: David Rosenberg

Organisation: GSK

Position: Vice president of IP policy

David Rosenberg has had a long career in intellectual property law. After achieving his law degree and qualifying as a solicitor, he spent three years conducting legal research and teaching in the US and UK. He has focused his practice primarily on litigation and transactional work for patent matters.

Rosenberg worked at Clifford Chance for 12 years and in 2001 joined GSK, where he engages in a policy role in the IP department. Rosenberg has worked with the UK Intellectual Property Office and the European Commission on IP policy matters inside and outside the EU.

These include providing access to medicines; launching a knowledge pool to facilitate research and development (R&D) of treatments for neglected tropical diseases; and helping with the IP policy of the Innovative Medicines Initiative, a public-private partnership which aims to remove the bottlenecks in R&D by conducting pre-competitive collaborative research in Europe using public and pharmaceutical industry resources.